ASCO 2024: Post-Stem Cell Transplant Cyclophosphamide Prophylaxis Boosts Overall Survival in Patients With Blood Cancer
Finding seen among patients with advanced blood cancer receiving transplants from HLA-mismatched, unrelated donors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.